Basel Medical (BMGL) Cash & Current Investments (2024 - 2025)

Basel Medical (BMGL) posted Cash & Current Investments of $1.0 million for Q4 2025, down 55.69% sequentially from $2.3 million in Q2 2025, and down 46.88% YoY from $2.0 million in Q4 2024.

Basel Medical (BMGL) Cash & Current Investments (2024 - 2025) Analysis & Trends

Basel Medical has reported Cash & Current Investments for 2 years, with the latest figure at $1.0 million in Q4 2025.

  • Quarterly Cash & Current Investments fell 46.88% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (down 46.88% YoY) and the FY2025 annual result came in at $2.3 million, up 59.34% from the prior year.
  • Cash & Current Investments fell to $1.0 million in Q4 2025 per BMGL's latest filing, from $2.3 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $2.3 million in Q2 2025 and troughed at $1.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 HCA Healthcare 88.19 Bn 90.61 Bn 15.19 Bn 1.01 Bn
2 Tenet Healthcare 21.59 Bn 21.56 Bn 4.45 Bn 2.17 Bn
3 Encompass Health 12.19 Bn 12.86 Bn 1.34 Bn 133.50 Mn
4 Davita 11.52 Bn 12.39 Bn 1.16 Bn 688.88 Mn
5 Ensign 10.59 Bn 10.27 Bn 306.24 Mn 320.84 Mn
6 Universal Health Services 8.79 Bn 8.72 Bn 3.29 Bn 138.80 Mn
7 Pacs 7.04 Bn 6.88 Bn 338.46 Mn 164.45 Mn
8 Chemed 6.96 Bn 6.92 Bn 221.47 Mn 40.22 Mn
9 Concentra Group Holdings Parent 4.52 Bn 4.38 Bn 192.10 Mn 158.04 Mn
10 Basel Medical 98.81 Mn 98.02 Mn - 1.04 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.04 Mn
Jun 30, 2025 2.34 Mn
Dec 31, 2024 1.95 Mn
Jun 30, 2024 1.44 Mn